The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction
Crossref DOI link: https://doi.org/10.1007/s13300-017-0302-3
Published Online: 2017-10-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trevisan, Roberto http://orcid.org/0000-0003-0420-4468
Text and Data Mining valid from 2017-10-05
Article History
Received: 3 July 2017
First Online: 5 October 2017